Sonnet BioTherapeutics Holdings, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Return On Assets for the quarter ending September 30, 2024 was -150 %, a 32.8% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Return On Assets for 2024 was -150 %, a 32.8% increase from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Return On Assets for 2023 was -223 %, a 7.72% increase from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Return On Assets for 2022 was -242 %, a 13.4% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -150 +73.3 +32.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -142 +123 +46.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -126 +210 +62.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -170 +179 +51.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -223 +18.7 +7.72% Jul 1, 2023 Sep 30, 2023
Q2 2023 -265 -103 -63.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -336 -183 -120% Jan 1, 2023 Mar 31, 2023
Q4 2022 -349 -192 -122% Oct 1, 2022 Dec 31, 2022
Q3 2022 -242 -28.7 -13.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -162 +234 +59.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -153 +401 +72.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -157 +82.6 +34.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -213 -83.5 -64.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -396 -272 -220% Apr 1, 2021 Jun 30, 2021
Q1 2021 -554 -516 -1362% Jan 1, 2021 Mar 31, 2021
Q4 2020 -239 -214 -830% Oct 1, 2020 Dec 31, 2020
Q3 2020 -130 -111 -582% Jul 1, 2020 Sep 30, 2020
Q2 2020 -124 -115 -1364% Apr 1, 2020 Jun 30, 2020
Q1 2020 -37.9 -30.5 -409% Jan 1, 2020 Mar 31, 2020
Q4 2019 -25.8 -9.33 -56.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -19.1 +1.06 +5.27% Jul 1, 2019 Sep 30, 2019
Q2 2019 -8.44 +12.9 +60.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -7.45 +17.3 +69.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -16.4 +4.81 +22.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -20.1 +1.44 +6.68% Jul 1, 2018 Sep 30, 2018
Q2 2018 -21.4 -2.64 -14.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -24.8 +2.53 +9.27% Jan 1, 2018 Mar 31, 2018
Q4 2017 -21.2 +3.71 +14.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 -21.6 +2.23 +9.37% Jul 1, 2017 Sep 30, 2017
Q2 2017 -18.7 +12.7 +40.4% Apr 1, 2017 Jun 30, 2017
Q1 2017 -27.3 -0.57 -2.13% Jan 1, 2017 Mar 31, 2017
Q4 2016 -24.9 +3.46 +12.2% Oct 1, 2016 Dec 31, 2016
Q3 2016 -23.8 +10.7 +31% Jul 1, 2016 Sep 30, 2016
Q2 2016 -31.4 -6.25 -24.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -26.7 -7.33 -37.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -28.4 -8.88 -45.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -34.5 -17.5 -103% Jul 1, 2015 Sep 30, 2015
Q2 2015 -25.2 +0.17 +0.67% Apr 1, 2015 Jun 30, 2015
Q1 2015 -19.4 +14.1 +42% Jan 1, 2015 Mar 31, 2015
Q4 2014 -19.5 +20.7 +51.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -17 +21.1 +55.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -25.4 +13.5 +34.7% Apr 1, 2014 Jun 30, 2014
Q1 2014 -33.5 +6.95 +17.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -40.3 +1.37 +3.29% Oct 1, 2013 Dec 31, 2013
Q3 2013 -38.1 +4.76 +11.1% Jul 1, 2013 Sep 30, 2013
Q2 2013 -38.8 +11.6 +23.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -40.4 +19.6 +32.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 -41.6 Oct 1, 2012 Dec 31, 2012
Q3 2012 -42.9 Jul 1, 2012 Sep 30, 2012
Q2 2012 -50.4 Apr 1, 2012 Jun 30, 2012
Q1 2012 -60 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.